investorscraft@gmail.com

Intrinsic ValueCare Twentyone Corporation (2373.T)

Previous Close¥430.00
Intrinsic Value
Upside potential
Previous Close
¥430.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Care Twentyone Corporation operates as a leading provider of nursing care services in Japan, addressing the growing demand for elderly and disability support in an aging society. The company’s diversified service portfolio includes home-visit care, paid nursing homes, dementia group homes, and welfare equipment rentals, alongside ancillary businesses like meal delivery and employment support for people with disabilities. Its integrated approach ensures recurring revenue streams while catering to a broad demographic. Positioned in Japan’s highly regulated healthcare sector, Care Twentyone leverages its extensive network and operational expertise to maintain a competitive edge. The company’s focus on small-scale, community-based care aligns with government policies promoting decentralized elderly care, enhancing its market relevance. Additionally, its real estate development and human resource dispatch services create synergies, reinforcing its role as a comprehensive care solutions provider. With Japan’s aging population driving sustained demand, Care Twentyone is well-placed to capitalize on long-term industry tailwinds.

Revenue Profitability And Efficiency

Care Twentyone reported revenue of JPY 45.4 billion for FY 2024, with net income of JPY 278 million, reflecting modest profitability in a cost-intensive sector. Operating cash flow stood at JPY 710 million, though capital expenditures of JPY -1.08 billion indicate ongoing investments in infrastructure. The company’s ability to generate positive cash flow despite high operational costs underscores its efficiency in a regulated, labor-driven industry.

Earnings Power And Capital Efficiency

The company’s diluted EPS of JPY 20.63 highlights its earnings capacity, though margins remain constrained by sector-wide labor and regulatory costs. With a beta of 0.41, Care Twentyone exhibits lower volatility compared to the broader market, suggesting stable earnings power. However, its capital efficiency is tempered by significant debt levels, which may limit near-term flexibility.

Balance Sheet And Financial Health

Care Twentyone’s balance sheet shows JPY 3.08 billion in cash against JPY 19.5 billion in total debt, indicating leveraged financial health. While the debt load is substantial, the company’s steady cash flow generation provides some cushion. The healthcare sector’s defensive nature may mitigate liquidity risks, but deleveraging could be a priority to improve long-term stability.

Growth Trends And Dividend Policy

Growth is underpinned by Japan’s demographic trends, though near-term expansion may be tempered by high capex. The dividend payout of JPY 17 per share reflects a commitment to shareholder returns, albeit with a modest yield. Future growth will likely hinge on operational scalability and government policy support for elderly care services.

Valuation And Market Expectations

With a market cap of JPY 5.29 billion, Care Twentyone trades at a modest valuation, reflecting its niche positioning and debt burden. Investors likely price in steady but slow growth, given the sector’s structural tailwinds and regulatory constraints. The low beta suggests market expectations of resilience amid economic cycles.

Strategic Advantages And Outlook

Care Twentyone’s strategic advantage lies in its integrated service model and alignment with Japan’s aging population needs. While regulatory and cost pressures persist, the company’s diversified revenue streams and community-focused approach position it for sustainable, if gradual, growth. The outlook remains stable, with potential upside from policy tailwinds and operational efficiencies.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount